Substances | 6 min read
Medically Reviewed By
October 27, 2025
Written By
On October 27, 2025
If you’ve been prescribed trazodone 50 mg or are considering this medication, you might wonder whether it’s classified as a narcotic. The straightforward answer is no. Trazodone, even at 50 mg, is not a narcotic or controlled substance. Instead, it’s an atypical antidepressant that belongs to a class of medications known as serotonin antagonist and reuptake inhibitors (SARIs).
Many people might wonder if trazodone is a narcotic because it produces sedative effects similar to some controlled substances, and it’s frequently prescribed as a sleep aid. The drowsiness it causes can lead to confusion about its classification. However, trazodone functions very differently from narcotics in terms of its mechanism of action and regulatory status.
Throughout this article, we’ll explore trazodone’s classification, how it works compared to narcotics, its approved and off-label uses, typical dosage ranges, and important safety considerations.
Trazodone is an atypical antidepressant medication in the serotonin antagonist and reuptake inhibitor (SARI) class of drugs [1]. Originally FDA-approved for treating major depressive disorder, it’s now frequently prescribed off-label for insomnia and anxiety disorders. Unlike selective serotonin reuptake inhibitors (SSRIs), trazodone both blocks serotonin reuptake and antagonizes certain serotonin receptors, contributing to its antidepressant effects and sedative qualities.
Importantly, trazodone is not classified as a controlled substance under the Controlled Substances Act [2]. This reflects its low abuse potential compared to narcotics and benzodiazepines. While physical dependence can develop with prolonged use, trazodone doesn’t produce the euphoric “high” that characterizes drugs with significant abuse potential.
Narcotics, more accurately called opioids, are substances that bind to opioid receptors in the brain and body [3]. When activated by opioid medications like morphine, oxycodone, or hydrocodone, they produce powerful pain relief, sedation, and often euphoria. This euphoric effect is what gives opioids their high abuse potential and leads to their classification as controlled substances.
Trazodone works through an entirely different mechanism. Rather than targeting opioid receptors, trazodone modulates serotonin, a neurotransmitter that is involved in mood regulation, sleep, and various other bodily functions. It blocks its reuptake and antagonizes certain serotonin receptors, particularly 5-HT2A, influencing mood and promoting sedation without activating the reward pathways that opioids stimulate [1]. At lower doses, it also inhibits histamine H₁ and α‑1‑adrenergic receptors, producing a hypnotic effect that helps initiate and maintain sleep [4].
While both trazodone and narcotics can cause drowsiness and physical dependence with extended use, the similarities end there. Trazodone doesn’t produce the characteristic euphoria associated with narcotics, nor does it carry the same risk of respiratory depression that makes opioid overdoses so dangerous.
The dosage of trazodone you take doesn’t change its classification. Whether you’re prescribed 50 mg or 400 mg, trazodone remains a non-narcotic, non-controlled medication. The 50 mg dose is particularly common and represents a typical low dose primarily used for treating insomnia rather than depression.
For sleep and insomnia, healthcare providers typically prescribe between 50 and 100 mg taken at bedtime [4]. Many patients start at 50 mg, which may be increased gradually if needed. At these lower doses, trazodone’s sedative effects are most prominent, helping individuals fall asleep more easily.
When treating depression, doses range from 150 to 600 mg daily [1]. At these higher doses, trazodone functions more fully as an antidepressant, though it may take several weeks to notice improvements in mood.
The 50 mg dose sits at the lower end of the therapeutic range, which is why it’s primarily used for its sedative properties. At this dose, trazodone works through its antihistamine properties, blocking histamine receptors that promote wakefulness [4]. This sedation typically occurs within 30 minutes to an hour after taking the medication.
The absence of euphoria is a critical distinction. When someone takes a narcotic, the activation of opioid receptors causes a surge of dopamine in areas of the brain associated with pleasure and reward [3]. This creates feelings of intense well-being and euphoria, which reinforces the desire to take the drug again and can lead to addiction.
Trazodone doesn’t activate these reward pathways. While it can cause drowsiness and relaxation through its effects on serotonin and histamine, it doesn’t produce the pleasurable rush associated with narcotics [3]. Most people taking trazodone simply feel sleepy or calm, not euphoric. This is why trazodone has minimal abuse potential and isn’t sought after for recreational use.
Both trazodone and narcotics can lead to physical dependence, but the nature and implications differ significantly. With narcotics, physical dependence develops as the body adapts to constant opioid receptor activation. Stopping suddenly triggers severe withdrawal symptoms, including pain, nausea, sweating, anxiety, and intense cravings.
Trazodone can also cause physical dependence with regular use. If stopped abruptly, withdrawal symptoms may include anxiety, agitation, sleep disturbances, and flu-like symptoms [5]. However, trazodone withdrawal typically lacks the intense physical discomfort and psychological cravings characteristic of narcotic withdrawal. People taking trazodone as prescribed rarely develop the compulsive drug-seeking behavior that defines addiction. Tapering off trazodone gradually under medical supervision usually minimizes withdrawal symptoms effectively.
Trazodone’s properties position it as a versatile medication with several clinical applications. As a non-controlled, prescription-only medication, it offers therapeutic benefits without the regulatory restrictions associated with controlled substances. When used as prescribed, trazodone is considered non-addictive.
The FDA has approved trazodone specifically for treating major depressive disorder [1]. However, healthcare providers frequently prescribe trazodone off-label for insomnia. The medication’s ability to promote sleep without the dependence risks associated with traditional sleep medications like benzodiazepines makes it an attractive option.
Beyond depression and insomnia, trazodone finds use in treating various anxiety disorders. Some healthcare providers also prescribe it off-label for conditions such as chronic pain and post-traumatic stress disorder (PTSD), particularly when sleep disturbances accompany these conditions [1].
While trazodone is not a narcotic, there are some important things to consider when taking this medication. Trazodone can interact with various medications and substances, some of which pose serious health risks. Monoamine oxidase inhibitors (MAO inhibitors), which are a different class of antidepressants, represent one of the most significant interaction risks. Combining trazodone with MAO inhibitors can lead to serotonin syndrome, a potentially life-threatening condition.
Other medications that increase serotonin levels can also create dangerous interactions. These include antidepressants, like selective serotonin reuptake inhibitors (SSRIs), serotonin–norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants, and certain migraine medications. Some antifungal medications can increase trazodone levels in the blood, which can potentially lead to increased side effects.
Alcohol deserves special mention. Combining alcohol with trazodone significantly increases drowsiness and impairment. This combination can lead to dangerous situations such as falls or accidents. Other sedative medications similarly increase drowsiness when combined with trazodone.
Common side effects of trazodone include drowsiness, dizziness (particularly when standing up quickly), dry mouth, blurred vision, headache, and nausea [5]. Less common but more serious side effects require immediate medical attention. These include irregular heart rhythm, low blood pressure, priapism (a painful erection lasting longer than four hours), hyponatremia (low sodium levels), and serotonin syndrome [5], a potentially life-threating condition caused by excessive serotonin levels.
Elderly patients face increased risks, particularly for hyponatremia and falls. Pregnant women should exercise caution due to limited safety data. Trazodone is also not recommended for children because its efficacy and safety haven’t been established in pediatric populations [5].
Trazodone, including the commonly prescribed 50 mg dose, is not a narcotic or controlled substance. This atypical antidepressant works through serotonin modulation rather than opioid receptor activation, fundamentally distinguishing it from narcotic medications [3]. Its classification reflects its low abuse potential, though physical dependence can develop with consistent, prolonged use.
The medication serves dual purposes in clinical practice. As an FDA-approved treatment for major depressive disorder, trazodone helps improve mood at higher doses. As an off-label sleep aid, it promotes sedation within 30 minutes at lower doses like 50 mg, offering an alternative to habit-forming sleep medications.
Safe trazodone use requires awareness of potential side effects and drug interactions. Medical supervision throughout treatment ensures the best outcomes, especially for individuals with comorbid mental health conditions or substance use disorders.
If you’re struggling with sleep difficulties, depression, or concerns about your current medications, we understand how challenging these experiences can be. At Ascendant NY, we provide comprehensive, compassionate care for individuals facing mental health and substance use challenges throughout New York City’s five boroughs and Long Island. Our medication-assisted treatment programs can help you find safe, effective solutions tailored to your unique needs. Contact us today to learn more about how we can help.
No, trazodone 50 mg is not a controlled medication under federal or state regulations [2]. The Drug Enforcement Administration does not classify trazodone as a controlled substance because it has low abuse potential compared to narcotics and benzodiazepines. While trazodone requires a prescription and can cause physical dependence with prolonged use, it doesn’t produce the euphoric effects that typically lead to medication misuse [3].
Trazodone typically does not cause positive results on standard drug screens for narcotics or opioids. Standard drug tests look for specific substances, and trazodone’s chemical structure differs significantly from opioids. If you’re facing a drug test, inform the testing facility that you’re taking trazodone as prescribed.
Trazodone is not scheduled under the Controlled Substances Act [2], meaning it has no schedule classification. The DEA assigns schedule classifications to drugs based on their abuse potential. Because trazodone has low abuse potential and doesn’t produce reinforcing effects associated with addiction, it doesn’t meet the criteria for controlled substance scheduling.
Trazodone has significantly lower addiction potential compared to narcotic pain relievers [3]. Narcotics activate the brain’s reward pathways, producing euphoria that reinforces continued use. Trazodone doesn’t create these rewarding effects because it works through serotonin modulation rather than opioid receptor activation. While physical dependence can develop with regular use, this differs from addiction.
Healthcare providers sometimes use trazodone as part of managing opioid withdrawal, particularly for addressing severe insomnia [6]. Trazodone’s sedating properties help improve sleep quality without introducing another potentially addictive substance. However, it doesn’t directly address other withdrawal symptoms. At Ascendant NY, we offer medication-assisted treatment programs that address both the physical and psychological aspects of recovery.
Our team is here to guide you with compassionate, evidence-based support. Connect with Ascendant New York today.
Here at Ascendant New York, we understand the importance of having access to accurate medical information you can trust, especially when you or a loved one is suffering from addiction. Find out more on our policy.
[1] StatPearls. (2025). Trazodone. In StatPearls [Internet]. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK470560/
[2] Kadiyala, S., Chenoweth, M., & Watanabe, J. H. (2025). Off‑label policy through the lens of trazodone usage and spending in the United States. Health Affairs Scholar, 3(7). https://pmc.ncbi.nlm.nih.gov/articles/PMC12278056/
[3] Dhaliwal, A., & Gupta, M. (2023). Physiology, opioid receptor. In StatPearls [Internet]. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK546642/
[4] Jaffer, K. Y., Chang, T., Vanle, B., et al. (2017). Trazodone for insomnia: A systematic review. Innovations in Clinical Neuroscience, 14(7–8), 24–34. https://pmc.ncbi.nlm.nih.gov/articles/PMC5842888/
[5] Mayo Clinic. (n.d.). Trazodone (oral route) – side effects, dosage & warnings. Mayo Clinic. Retrieved October 28, 2025, from https://www.mayoclinic.org/drugs-supplements/trazodone-oral-route/description/drg-20061280
[6] Cleveland Clinic. (2024). Opiate and opioid withdrawal: Causes, symptoms & treatment. Cleveland Clinic. Retrieved October 28, 2025, from https://my.clevelandclinic.org/health/diseases/opioid-withdrawal